Gourdeau, H <br/><br/>
Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Mar 2001 
 - 236-40 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s002800000223  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Cell Division--drug effects<br/>Cytidine Deaminase--metabolism<br/>Cytosine--analogs & derivatives<br/>Dioxolanes--therapeutic use<br/>Female<br/>HL-60 Cells<br/>Humans<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Leukemia, T-Cell--drug therapy<br/>Mice<br/>Mice, SCID<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured